Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation

Genetic Testing

Volumn 8, Issue 2, 2004, Pages 163-168

  Neocleous, Vassos ^a   Passalaris, Tina ^b   Spanou, Elena ^a   Kitsios, Petros ^b   Skordis, Nicos ^c   Deltas, C Constantinou ^a,d  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b Bank of Cyprus Group Oncology Centre   (Cyprus)

^c Makarios III Hospital   (Cyprus)

^d UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; PROTEIN RET; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CYPRUS; DNA SEQUENCE; DNA TEMPLATE; EXON; FEMALE; GENE MUTATION; GENETIC SCREENING; GERM LINE; HUMAN; MALE; MISSENSE MUTATION; MULTIGENE FAMILY; MULTIPLE ENDOCRINE ADENOMATOSIS; ONCOGENE RET; PROTO ONCOGENE; THYROID MEDULLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; CYPRUS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; ONCOGENE PROTEINS; PEDIGREE; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 4143105645     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2004.8.163     Document Type: Article

References (27)

1. ASAI, N., IWASHITA, T., MITSUYAMA, M., et al. (1995). Mechanism of activation of the RET proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol. Cell Biol. 15, 1613-1619.
2. BRANDI, M.L., GAGEL, R.F., ANGELI, A., et al. (2001). Guidelines for diagnosis and therapy of MEN type 1 and MEN type 2. J. Clin. Endocr. Metab. 86, 5658-5671.
3. CARNEY, J.A., GO, V.L., SIZEMORE, G.W., et al. (1976). Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2B. N. Engl. J. Med. 295, 1287-1291.
4. DONOVAN, D.T., LEVY, M.L., FURST, E.J., et al. (1989). Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variant. Henry Ford Hosp. Med. J. 37, 147-150.
5. DURBEC, P., MARCOS GUTIERREZ, C.V., KILKENNY, C., et al. (1996). GDNF signaling through the ret receptor tyrosine kinase. Nature 381, 789-793.
6. EDERY, G., LYONNET, S., MULLIGAN, L.M., et al. (1994). Mutations of the RET proto-oncogene in Hirchsprung's disease. Nature 367, 378-380.
7. ENG, C., and MULLIGAN, L.M. (1997). Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirchsprung's disease. Hum. Mutat. 9, 97-109.
8. ENG, C., CLAYTON, D., SHUFFENECKER, I., et al. (1996). The relationship between specific ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International ret mutation consortium analysis. J. Am. Med. Assn. 276, 1575-1579.
9. FARDON, J.R., LEIGHT, G.S., DILLEY, W.G., et al. (1986). Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br. J. Surg. 73, 278-281.
10. FRANK-RAW, K., KRUTT, T., HOPPNER, W., et al. (1996). Diagnosis and mamnagement of pheochromocytomas in patients with multiple endocrine neoplasia type 2: relevance of specific mutations in the RET protooncogene. Eur. J. Endocrinol. 135, 222-225.
11. GAGEL, R.F., TASHJIAN, A.H., JR., CUMMINGS, T., et al. (1988). The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a: an 18-year experience. N. Engl. J. Med. 318, 478-484.
12. HOFSTRA, R.M., LANDSVATER, R.M., CECCHERINI, I., et al. (1994). A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367, 375-376.
13. KOPTIDES, M., CONSTANTINIDES, R., PATSALIS, C. P., et al. (1998). Loss of heterozygocity in polycystic kidney disease with a missense mutation in the repeated region of PKD1. Hum. Genet. 1031, 709-717.
14. MATHEW, C.P.G., SMITH, B.A., THORPE, K., et al. (1987). Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328, 524-526.
15. MULLIGAN, L.M., ENG, C., HEALY, C.S., et al. (1994). Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet. 6, 70-74.
16. NUNZIATA, V., GIANNATTASIO, R., DI GIOVANNI, G., et al. (1989). Hereditary localized prurittus in affected members of a kindred with multiple endocrine neoplasia type 2A. Clin. Endocrinol. 30, 57-63.
17. PAPOTTI, M., BOTTO MICCA, F., FAVERO, A., et al. (1993). Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions showing insular, trabecular and solid patterens. Am. J. Surg. Pathol. 17, 291-301.
18. PONDER, B.A.J. (1999). The phenotypes associated with RET mutation sin the multiple endocrine neoplasia type 2 syndrome. Cancer Res. 59, 1736-1742.
19. th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, (eds.). McGraw-Hill, New York pp. 931-942.
20. SANTORO, M., CARLOMAGNO, F., ROMANO, A., et al. (1995). Germ line mutations of MEN 2A and MEN 2B activate RET as dominant transforming gene by different molecular mechanisms. Science 267, 381-383.
21. SCHUFFENECKER, I., VIRALLY-MONOD, M., and BROHET, R. (1988). Le Groupe D'Etude des Tumeurs a Calcitonine: risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. J. Clin. Endocrinol. Metab. 83, 487-491.
22. SIMPSON, N.E., KIDD, K.K., GOODFELLOW, P.J., et al. (1987). Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328, 528-530.
23. STEINER, A.L., GOODMAN, A.D., and POWERS, S.R. (1968). Study of a kindred with pheochromocytoma, medullary carcinoma, hyperparathyroidism and Cushing's disease: Multiple Endocrine Neoplasia type 2. Medicine 47, 371-409.
24. TREANOR, J.J., GOODMAN, L., DeSAUVAGE, F., et al. (1996). Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83.
25. TRUPP, M., ARENAS, E., FAINZILBER, M., etal. (1996). Functional receptor for GDNF encoded by c-RET proto-oncogene. Nature 381, 785-789.
26. VERDY, M., WEBER, A.M., ROY, C.C., et al. (1982). Hirchsprung's disease in a family with multiple endocrine neoplasia type 2. J. Pediatr. Gastroenterol. Nutr. 1, 603-607.
27. WILLIAMS, E.D., and POLLOCK, D.J. (1966). Multiple mucosal neuromata with endocrine tumours: a syndrome allied to Von Recklighausen's disease. J. Pathol. Bacteriol. 91, 71-80.